APGE Strangle Strategy
APGE (Apogee Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.
APGE (Apogee Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $5.19B, a beta of 0.69 versus the broader market, a 52-week range of 34.34-95.315, average daily share volume of 880K, a public-listing history dating back to 2023, approximately 196 full-time employees. These structural characteristics shape how APGE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.69 indicates APGE has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a strangle on APGE?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current APGE snapshot
As of May 15, 2026, spot at $81.32, ATM IV 70.60%, IV rank 14.06%, expected move 20.24%. The strangle on APGE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.
Why this strangle structure on APGE specifically: APGE IV at 70.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a APGE strangle, with a market-implied 1-standard-deviation move of approximately 20.24% (roughly $16.46 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated APGE expiries trade a higher absolute premium for lower per-day decay. Position sizing on APGE should anchor to the underlying notional of $81.32 per share and to the trader's directional view on APGE stock.
APGE strangle setup
The APGE strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With APGE near $81.32, the first option leg uses a $85.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed APGE chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 APGE shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $85.00 | $7.40 |
| Buy 1 | Put | $75.00 | $6.00 |
APGE strangle risk and reward
- Net Premium / Debit
- -$1,340.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$1,340.00
- Breakeven(s)
- $61.60, $98.40
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
APGE strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on APGE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$6,159.00 |
| $17.99 | -77.9% | +$4,361.08 |
| $35.97 | -55.8% | +$2,563.16 |
| $53.95 | -33.7% | +$765.24 |
| $71.93 | -11.6% | -$1,032.68 |
| $89.91 | +10.6% | -$849.40 |
| $107.89 | +32.7% | +$948.52 |
| $125.86 | +54.8% | +$2,746.44 |
| $143.84 | +76.9% | +$4,544.36 |
| $161.82 | +99.0% | +$6,342.28 |
When traders use strangle on APGE
Strangles on APGE are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the APGE chain.
APGE thesis for this strangle
The market-implied 1-standard-deviation range for APGE extends from approximately $64.86 on the downside to $97.78 on the upside. A APGE long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current APGE IV rank near 14.06% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on APGE at 70.60%. As a Healthcare name, APGE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to APGE-specific events.
APGE strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. APGE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move APGE alongside the broader basket even when APGE-specific fundamentals are unchanged. Always rebuild the position from current APGE chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on APGE?
- A strangle on APGE is the strangle strategy applied to APGE (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With APGE stock trading near $81.32, the strikes shown on this page are snapped to the nearest listed APGE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are APGE strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the APGE strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 70.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,340.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a APGE strangle?
- The breakeven for the APGE strangle priced on this page is roughly $61.60 and $98.40 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current APGE market-implied 1-standard-deviation expected move is approximately 20.24%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on APGE?
- Strangles on APGE are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the APGE chain.
- How does current APGE implied volatility affect this strangle?
- APGE ATM IV is at 70.60% with IV rank near 14.06%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.